MY8500619A - Antihypertensive pharmaceutical compositions - Google Patents

Antihypertensive pharmaceutical compositions

Info

Publication number
MY8500619A
MY8500619A MY619/85A MY8500619A MY8500619A MY 8500619 A MY8500619 A MY 8500619A MY 619/85 A MY619/85 A MY 619/85A MY 8500619 A MY8500619 A MY 8500619A MY 8500619 A MY8500619 A MY 8500619A
Authority
MY
Malaysia
Prior art keywords
pharmaceutical compositions
antihypertensive pharmaceutical
antihypertensive
compositions
pharmaceutical
Prior art date
Application number
MY619/85A
Other languages
English (en)
Inventor
David Grenville Holmes
Walter H Aellig
Pavel Jerie
Walter Schutz
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of MY8500619A publication Critical patent/MY8500619A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MY619/85A 1979-02-22 1985-12-30 Antihypertensive pharmaceutical compositions MY8500619A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH178579A CH643457A5 (de) 1979-02-22 1979-02-22 Pharmazeutische praeparate zur behandlung der hypertonie.

Publications (1)

Publication Number Publication Date
MY8500619A true MY8500619A (en) 1985-12-31

Family

ID=4218544

Family Applications (1)

Application Number Title Priority Date Filing Date
MY619/85A MY8500619A (en) 1979-02-22 1985-12-30 Antihypertensive pharmaceutical compositions

Country Status (20)

Country Link
JP (1) JPS55115823A (nl)
AT (1) AT378915B (nl)
AU (1) AU538599B2 (nl)
BE (1) BE881763A (nl)
CA (1) CA1147657A (nl)
CH (1) CH643457A5 (nl)
DE (1) DE3005029C2 (nl)
FR (1) FR2449450A1 (nl)
GB (1) GB2044101B (nl)
HU (1) HU187271B (nl)
IE (1) IE49073B1 (nl)
IL (1) IL59432A (nl)
IT (1) IT1145433B (nl)
MY (1) MY8500619A (nl)
NL (1) NL8001000A (nl)
NZ (1) NZ192924A (nl)
PH (1) PH17118A (nl)
PT (1) PT70855A (nl)
SE (2) SE8001121L (nl)
ZA (1) ZA801018B (nl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2537434A1 (fr) * 1982-12-09 1984-06-15 Sandoz Sa Composition pharmaceutique d'endralazine sous forme retard
GB2367242B (en) * 2000-09-21 2004-07-28 Henderson Morley Res & Dev Ltd Antiviral treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2458155A1 (de) * 1973-12-19 1975-07-03 Sandoz Ag Neue pharmazeutische praeparate

Also Published As

Publication number Publication date
IL59432A (en) 1984-08-31
FR2449450B1 (nl) 1983-07-22
GB2044101B (en) 1983-09-07
AU5574280A (en) 1980-08-28
NL8001000A (nl) 1980-08-26
JPS55115823A (en) 1980-09-06
IT8047950A0 (it) 1980-02-20
DE3005029C2 (de) 1987-02-12
PH17118A (en) 1984-06-01
ZA801018B (en) 1981-09-30
IT1145433B (it) 1986-11-05
HU187271B (en) 1985-12-28
IE49073B1 (en) 1985-07-24
DE3005029A1 (de) 1980-09-04
BE881763A (fr) 1980-08-18
CA1147657A (en) 1983-06-07
GB2044101A (en) 1980-10-15
IE800336L (en) 1980-08-22
PT70855A (fr) 1980-03-01
NZ192924A (en) 1984-05-31
SE8202357L (en) 1982-04-15
SE8001121L (sv) 1980-08-23
FR2449450A1 (fr) 1980-09-19
IL59432A0 (en) 1980-05-30
CH643457A5 (de) 1984-06-15
AU538599B2 (en) 1984-08-23
AT378915B (de) 1985-10-25
ATA95580A (de) 1985-03-15

Similar Documents

Publication Publication Date Title
IL60555A0 (en) Pharmaceutical compositions containing certain ureal derivatives
IL58279A0 (en) Sustained release pharmaceutical compositions
GB2053682B (en) Sustained release pharmaceutical compositions
AU535604B2 (en) Pharmaceutical compositions
NZ192615A (en) Substituted phenyl j-substituted piperidinoalkanone derivatives and pharmaceutical compositions
DE3064927D1 (en) Gall-stone dissolution compositions
NZ193798A (en) 3-thiovinyl-cephalosporin derivatives and pharmaceutical compositions
NZ194421A (en) 3-amino-sydnone-imines pharmaceutical compositions
DE3072103D1 (en) Pharmaceutical compositions containing 3-amino-pyrazoline derivatives
PH16443A (en) Substituted tetraazetricyclic compounds and their pharmaceutical compositions
EG15103A (en) Oxytetrocycline compositions
IE800872L (en) Tickicidal compositions
AU535605B2 (en) Pharmaceutical compositions
GB2048671B (en) Pharmaceutical composition containing dihydroegotoxine
ZA806383B (en) Long acting pharmaceutical composition
AU6501980A (en) Pharmaceutical compositions
NZ193533A (en) 2-isopropylamino-5-halogeno-pyrimidines pharmaceutical compositions
IL60600A (en) Pharmaceutical compositions comprising certain azolylalkenol compounds
GB2044101B (en) Antihypertensive pharmaceutical compositions
PH16570A (en) Schistosomicidal compositions
ZA803634B (en) Water-settable compositions
GB2062462B (en) Compositions phthalazinol
GB2049416B (en) Pharmaceutical composition
NZ192520A (en) Hydantoin derivatives pharmaceutical compositions
EG14325A (en) Pesticidel compositions